FDA Launches PreCheck Program to Strengthen U.S. Drug Manufacturing and Reduce Dependence on China
Originally Published 5 months ago — by fda.gov

The FDA announced the new PreCheck program to enhance U.S. drug manufacturing by streamlining regulatory processes and encouraging domestic production, aiming to reduce reliance on overseas sources for pharmaceuticals and active ingredients, with a public meeting scheduled for September 30, 2025.
